/ricerca/ansaen/search.shtml?any=
Show less

Se hai scelto di non accettare i cookie di profilazione e tracciamento, puoi aderire all’abbonamento "Consentless" a un costo molto accessibile, oppure scegliere un altro abbonamento per accedere ad ANSA.it.

Ti invitiamo a leggere le Condizioni Generali di Servizio, la Cookie Policy e l'Informativa Privacy.

Puoi leggere tutti i titoli di ANSA.it
e 10 contenuti ogni 30 giorni
a €16,99/anno

  • Servizio equivalente a quello accessibile prestando il consenso ai cookie di profilazione pubblicitaria e tracciamento
  • Durata annuale (senza rinnovo automatico)
  • Un pop-up ti avvertirà che hai raggiunto i contenuti consentiti in 30 giorni (potrai continuare a vedere tutti i titoli del sito, ma per aprire altri contenuti dovrai attendere il successivo periodo di 30 giorni)
  • Pubblicità presente ma non profilata o gestibile mediante il pannello delle preferenze
  • Iscrizione alle Newsletter tematiche curate dalle redazioni ANSA.


Per accedere senza limiti a tutti i contenuti di ANSA.it

Scegli il piano di abbonamento più adatto alle tue esigenze.

Pharmaceutical companies compared in Copenhagen

Pharmaceutical companies compared in Copenhagen

Meeting between Danish and Italian experts and operators

ROMA, 01 April 2025, 15:12

ANSA English Desk

ANSACheck
- ALL RIGHTS RESERVED

- ALL RIGHTS RESERVED

A meeting between Danish and Italian institutions, research centres, companies and experts from the pharmaceutical industry took place at the Italian Ambassador's Residence in Copenhagen. The aim of the meeting was to identify and promote possible collaborations, particularly with regard to artificial intelligence applications in the pharmaceutical sector.
    The round tables saw the participation and contribution of various representatives of institutions and companies from the two countries; the discussion took place on various topics, such as supercomputers, the use of artificial intelligence and biobanks, while also proposing concrete solutions for building lasting bilateral relations between the companies in the field of innovation and research. The importance of the collaboration needed to strengthen and speed up the outcomes of research and innovations by improving the data/artificial intelligence connection and the special role of academia was also emphasised.

ALL RIGHTS RESERVED © Copyright ANSA

Not to be missed

Share

Or use

ANSA Corporate

If it is news,
it is an ANSA.

We have been collecting, publishing and distributing journalistic information since 1945 with offices in Italy and around the world. Learn more about our services.